Longitudinal dynamics of symptom networks in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a prospective cohort study - Scorecard - MDSpire
Advertisement
Longitudinal dynamics of symptom networks in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a prospective cohort study
Clinical Scorecard: Temporal Changes in Symptom Networks Among Differentiated Thyroid Cancer Patients Undergoing Radioactive Iodine Treatment: A Prospective Cohort Analysis
At a Glance
Category
Detail
Condition
Differentiated Thyroid Cancer (DTC)
Key Mechanisms
Symptom network dynamics during Radioactive Iodine (RAI) therapy.
Target Population
Patients with differentiated thyroid cancer undergoing RAI therapy.
Care Setting
Oncology outpatient and inpatient settings.
Key Highlights
Significant changes in symptom network structure observed across treatment phases.
Psychological distress consistently showed the highest centrality throughout treatment.
Throat/mouth symptoms identified as critical bridges between physical and psychological symptoms.
Predictability of treatment-related physical symptoms increased substantially post-treatment.
Findings suggest a need for targeted psychological interventions during treatment transitions.
Guideline-Based Recommendations
Diagnosis
Confirm diagnosis of differentiated thyroid cancer through pathological evaluation.
Management
Implement Radioactive Iodine therapy as part of post-surgical management.
Monitoring & Follow-up
Assess symptom networks at multiple timepoints to understand dynamic changes.
Risks
Monitor for psychological distress and physical symptoms during RAI therapy.
Patient & Prescribing Data
520 patients with differentiated thyroid cancer receiving RAI therapy.
Psychological and physical symptoms co-occur and evolve during treatment.
Clinical Best Practices
Utilize network analysis to assess symptom interconnections.
Focus on bridge symptoms for potential intervention targets.
Provide psychological support during critical treatment transitions.